S

Comprehensive ARF Study Notes

Definition and Gas Exchange

  • Focus: Respiratory Failure (ARF) and its pathophysiology, assessment, and management.

  • Definition of respiration:

    • A single breath.

    • The movement of oxygen from outside the body to the cells of the tissues, and the removal of carbon dioxide from the body back into the environment.

  • Gas Exchange Unit in the lung:

    • Alveolus as the functional unit where gas exchange occurs.

    • Key vascular components:

    • Pulmonary artery → capillary network around alveoli → pulmonary vein.

    • Normal gas exchange depicted as coordinated air delivery and blood perfusion to alveoli.

    • Note: Fig. 68-1 referenced (normal gas exchange unit).

Acute Respiratory Failure (ARF): Definition and Classification

  • ARF is a condition, not a disease in itself; results from one or more diseases involving the lungs or other body systems.

  • Acute Respiratory Failure (ARF) results from inadequate gas exchange:

    • Inadequate O2 transfer to blood (oxygenation) → Hypoxemia.

    • Inadequate CO2 removal → Hypercapnia.

  • ARF is classified in two main ways:

    • Hypoxemic (oxygenation failure).

    • Hypercapnic (ventilatory failure).

  • Classification thresholds (as per slides):

    • Hypoxemic RF:

    • PaO2 ≤ 60 mm Hg on 60% oxygen.

    • Often referred to as oxygenation failure.

    • Hypercapnic RF:

    • PaCO2 > 45 mm Hg and pH < 7.35 (some sources use PaCO2 > 50 mm Hg with acidosis).

  • Timing distinctions:

    • Acute: minutes (to several hours).

    • Chronic: several hours to days or longer.

ARF Oxygenation (Hypoxemic RF) Mechanisms

  • Hypoxemic RF is caused by impaired oxygenation due to several mechanisms:

    • Ventilation/Perfusion (V/Q) mismatch.

    • Shunt (venous admixture).

    • Diffusion limitations.

    • Alveolar hypoventilation.

  • V/Q Mismatch:

    • Normal lung: Volume of blood perfusing alveoli roughly equals the amount of gas reaching alveoli each minute (4–6 L/min).

    • Ideal V/Q ratio is 1:1 (V/Q ≈ 1).

    • Normal range:

    • rac{V}{Q} ext{ in normal lungs} o 0.8 ext{ to } 1.2

    • Diseased lung: V and Q are not matched (V and Q are not 1:1).

  • Hypoxemic RF etiologies (V/Q Mismatch):

    • COPD, Pneumonia, Asthma, Atelectasis, Pain, Pulmonary embolus.

Hypoxemic RF: Shunts and Diffusion Limitations

  • Range of V/Q relationships (concepts):

    • Absolute shunt: no ventilation (airway/alveolar ventilation blocked) – blood bypasses gas exchange.

    • V/Q mismatch: ventilation partially compromised by airway secretions or obstructions.

    • Normal lung unit: balanced V and Q.

    • V/Q mismatch with emboli: perfusion partially blocked by emboli.

    • Dead space: no perfusion (pulmonary capillary occlusion).

  • Anatomic shunts (intravascular/ intracardiac):

    • Blood passes through an anatomic channel in the heart and bypasses the lungs.

    • Example: Ventricular septal defect (VSD).

  • Intrapulmonary (capillary) shunt:

    • Blood flows through pulmonary capillaries without participating in gas exchange.

    • Seen with alveolar filling processes: ARDS, pneumonia, pulmonary edema.

  • Diffusion limitation:

    • Gas exchange across the alveolar–capillary membrane is compromised due to membrane thickening or damage.

    • Associated diseases: Pulmonary fibrosis, ARDS, interstitial lung disease.

    • Hypoxemia may be present especially during exercise.

  • Alveolar hypoventilation:

    • Generalized decrease in ventilation.

    • Results in increased PaCO2 and decreased PaO2.

    • Primarily a hypercapnic problem but contributes to hypoxia.

    • Examples: Restrictive lung disease, CNS conditions, chest wall dysfunction, acute asthma.

Hypoxemic RF: Etiology and Combined Mechanisms

  • Often due to a combination of two or more physiologic mechanisms.

    • Example: Pneumonia can cause ARF via V/Q mismatch (inflammation, edema, exudate) and alveolar filling (shunt).

  • Hypoxemia can lead to hypoxia and shift metabolism to anaerobic pathways, producing lactic acid and metabolic acidosis if buffering is insufficient.

  • Lactic acid accumulation → metabolic acidosis; inadequate NaHCO3 buffering worsens acidosis.

Hypercapnic (Ventilatory) Respiratory Failure

  • Definition:

    • PaCO2 above normal (>50 mm Hg per some slides) with acidemia (pH < 7.35).

    • Acute increase in PaCO2 with insufficient compensation leads to acid-base imbalance.

    • Many patients experience both hypoxemic and hypercapnic RF.

  • CNS-related causes:

    • Opioid or other respiratory depressant overdose (decreases CO2 reactivity in brainstem).

    • CNS depressants (opioids, benzodiazepines).

    • Brainstem infarction or severe head injury (respiratory center dysfunction).

    • Spinal cord injury.

  • Chest wall and neuromuscular causes:

    • Morbid obesity; chest wall restriction and abdominal contents limiting expansion.

    • Rib fractures or flail chest; mechanical restriction; pain; muscle spasm; kyphoscoliosis.

    • Neuromuscular conditions: Muscular dystrophy, Myasthenia Gravis (acute exacerbation), Guillain–Barré syndrome, Multiple sclerosis.

  • Airway and alveoli problems and tissue demands:

    • Asthma, COPD, Cystic Fibrosis; airway obstruction and air trapping predispose to hypercapnic RF.

  • Tissue/organ needs and O2 utilization issues:

    • Major threat is inability of lungs to meet tissue O2 demands; delivery of O2 may be adequate but tissues cannot use it; stress increases tissue O2 consumption.

    • Failure of O2 utilization occurs in septic shock; adequate O2 delivery but impaired extraction or diffusion limits at cellular level; venous O2 can be abnormally high.

Clinical Presentation and Monitoring of ARF

  • Presentation: often patients sit upright (tripoding) with moderate to severe acute respiratory failure; rapid shallow or slower respiratory rate; substantial work of breathing; ability to speak reflects dyspnea level (sentences, phrases, words).

  • Physical signs: pursed-lip breathing, use of accessory muscles, retractions, paradoxical breathing.

  • Monitoring and trends: essential to monitor ABG and pulse oximetry trends; diagnostic tests are not substitutes for clinical assessment.

  • Early indicators and baseline: tachycardia, tachypnea, mild hypertension, diaphoresis are early signs; cyanosis is a late sign.

  • First indicator in many cases: deterioration continues when compensatory mechanisms fail.

Diagnostic Studies in ARF

  • History and physical assessment.

  • Arterial Blood Gas (ABG): pH, PaCO2, PaO2, HCO3 (derived CO2).

  • Chest X-ray: atelectasis, pneumonia, infiltrates.

  • Complete Blood Count (CBC): anemia or polycythemia.

  • Routine chemistry: renal and hepatic function; electrolytes (K+, Mg2+, phosphate) may aggravate RF.

  • Serum CK and Troponin I: to exclude myocardial infarction in the setting of RF.

Nursing Assessment and Care Planning

  • Nursing assessment domains:

    • Health history (medications, prior surgeries).

    • Health perception–health management.

    • Nutritional–metabolic; Activity–exercise; Sleep–rest; Cognitive–perceptual; Coping–stress tolerance.

    • Physical assessment: General, Neurologic, Cardiovascular, Respiratory, Gastrointestinal, Integumentary.

  • Priority problems in ARF:

    • Impaired gas exchange.

    • Ineffective airway clearance.

    • Ineffective breathing pattern.

    • Impaired respiratory system function.

    • Inadequate tissue perfusion.

  • Planning for care:

    • Patient will independently maintain a patent airway.

    • No dyspnea or abnormal breathing pattern at baseline.

    • Effective cough and the ability to clear secretions.

    • Normal ABG values (or at patient baseline).

    • Breath sounds within baseline.

Nursing Interventions and Respiratory Therapy

  • Identify patients at risk and recognize respiratory distress early.

  • Education and prevention:

    • Coughing and deep breathing.

    • Incentive spirometry.

    • Ambulation and mobilization.

    • Hydration and nutrition optimization.

    • Prevent atelectasis, pneumonia, and complications of immobility.

  • Treat underlying causes.

  • Respiratory therapy goals:

    • Maintain adequate oxygenation and ventilation.

    • Correct acid–base balance.

    • Interventions:

    • Oxygen therapy.

    • Mobilization of secretions.

    • Positive pressure ventilation (PPV).

Oxygen Therapy and Noninvasive Ventilation

  • Oxygen therapy goals:

    • Correct hypoxemia.

    • Maintain PaO2 ≥ 60\ \text{mmHg} and SaO2 ≥ 90% (or baseline values).

    • Oxygen device and FiO2 individualized to condition.

    • Risks to avoid: Oxygen toxicity; absorption atelectasis.

  • Low-flow oxygen details (examples):

    • Low-flow oxygen via nasal cannula (NC) or venturi masks with approximate FiO2 vs flow:

    • 1 L/min ≈ 0.24, 2 L/min ≈ 0.28, 3 L/min ≈ 0.32, 4 L/min ≈ 0.36, 5 L/min ≈ 0.40, 6 L/min ≈ 0.44, 7 L/min ≈ 0.48, 8 L/min ≈ 0.52, 9 L/min ≈ 0.56, 10 L/min ≈ 0.60

  • Shunt-related hypoxemia: Often not responsive to high FiO2; may require Positive Pressure Ventilation (PPV).

Positive Pressure Ventilation (PPV) and Noninvasive Ventilation

  • Noninvasive PPV options:

    • CPAP (continuous positive airway pressure).

    • BiPAP (bilevel positive airway pressure).

    • Not appropriate for patients with decreased level of consciousness, facial trauma, hemodynamic instability, or excessive secretions.

  • Noninvasive PPV (BiPAP) depiction: mask over the nose or nose-and-mouth; assists breathing and reduces work of breathing.

Pharmacologic Therapy in ARF

  • Goals of drug therapy:

    • Reduce airway inflammation and bronchospasm.

    • Relieve pulmonary congestion.

    • Treat infection.

    • Reduce anxiety, pain, and restlessness.

  • Anti-inflammatory and bronchodilator therapy:

    • Corticosteroids (e.g., IV methylprednisolone, Solu-Medrol).

    • Bronchodilators: Beta-agonists (Albuterol); Anticholinergics (Ipratropium); Theophylline.

  • Therapy to reduce pulmonary congestion:

    • Diuretics (IV furosemide/Lasix).

    • Morphine: reduces respiratory rate, prolongs expiration, may improve expiratory volume.

    • Nitroglycerin: vasodilator to improve coronary perfusion.

  • Infection management:

    • Chest X-rays to locate infection; sputum cultures to identify organism and antibiotic sensitivity.

    • IV antibiotics: e.g., Vancomycin, Levofloxacin, Ceftriaxone.

  • Anxiety, pain, and restlessness management:

    • Benzodiazepines (e.g., Lorazepam, Midazolam).

    • Opioids (e.g., Morphine, Fentanyl).

    • Address underlying causes (hypoxemia, pain, electrolyte imbalances, drug reactions) rather than relying solely on sedatives.

  • Nutrition:

    • Maintain protein and energy stores; consider enteral or parenteral nutrition.

    • Nutritional supplements as needed; involve a dietician; tailor caloric and fluid needs.

Gerontologic Considerations in ARF

  • Age-related changes: decreased ventilatory capacity and physiologic lung changes.

    • Alveolar dilation and larger air spaces; loss of surface area for gas exchange.

    • Diminished elastic recoil; decreased chest wall compliance.

  • Delayed ventilatory response:

    • PaO2 falls and PaCO2 rises more before respiratory drive is stimulated, contributing to respiratory insufficiency.

  • Risk factors for worse outcomes:

    • History of tobacco use accelerating age-related lung changes.

    • Poor nutritional status and reduced physiologic reserve.

    • Cardiovascular, respiratory, and autonomic nervous system vulnerabilities.

  • Increased susceptibility to delirium and hospital-acquired infections; complex polypharmacy considerations.

Key Formulas and Thresholds (summary)

  • Oxygenation threshold for RF:

    • PaO2 < 60 mmHg or SpO2 < 90% indicates significant risk for respiratory failure.

    • PaCO2 > 50 mmHg may correlate with respiratory acidosis and requires intervention.

  • Hypercapnic threshold (ventilatory failure):

    • Normal V/Q ratio and range:

    • Ideal: \frac{V}{Q} \approx 1.

    • Normal range: 0.8 \le \frac{V}{Q} \le 1.2

  • Hypoxemia and hypoxia relationship:

    • Hypoxemia refers to low PaO2; hypoxia refers to insufficient oxygen delivery to tissues (may occur with impaired utilization or diffusion).

  • Oxygen delivery considerations (conceptual):

    • Oxygen delivery depends on cardiac output, arterial oxygen content, and hemoglobin saturation; not explicitly in slides but foundational.

Quick Reference: Common ARF Etiologies by Mechanism

  • V/Q mismatch causes: COPD, Pneumonia, Asthma, Atelectasis, Pain, Pulmonary embolus.

  • Shunts: ARDS, pneumonia with alveolar flooding, pulmonary edema (intrapulmonary shunt); intracardiac shunt (e.g., VSD).

  • Diffusion limitation: Pulmonary fibrosis, interstitial lung disease, ARDS.

  • Alveolar hypoventilation: CNS depression, chest wall restriction, neuromuscular disorders, airway obstruction.

  • Hypercapnic RF etiologies: CNS depression, chest wall disease, neuromuscular weakness, airway disease with obstruction, COPD, obesity hypoventilation syndrome.

Connections to Practice and Real-World Relevance

  • Early recognition of at-risk patients and prompt intervention can prevent progression to severe ARF.

  • Monitoring ABG and SpO2 trends guides therapy and helps titrate oxygen and ventilation support.

  • Understanding the underlying mechanism (V/Q mismatch vs shunt vs diffusion limitation vs hypoventilation) directs therapy (e.g., high FiO2 for V/Q mismatch vs PPV for shunt).

  • Multidisciplinary approach includes nursing assessment, respiratory therapy, pharmacologic treatment, nutrition, and geriatric considerations to optimize outcomes.